Anticoagulation: Clinical Trials

10 trials for Anticoagulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 not yet recruiting, 1 enrolling by invitation, 1 recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Not yet recruiting 2, Enrolling by invitation 1, Recruiting 1, Unknown 1

Follow Anticoagulation: new trials by email Literature Review of Anticoagulation trials Research Report on Anticoagulation

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study
POCT test - Anticoagulation
Phase 4Not yet recruitingRenJi Hospital4162025-01-012024-10-16
Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves
Rivaroxaban - Anticoagulation
Phase 4Not yet recruitingRenJi Hospital2502024-08-012024-06-28
Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy
Warfarin, DAPT, CE+CABG - Anticoagulation, Coronary Endarterectomy
Phase 4RecruitingChina National Center for Cardiovascular Diseases2022023-04-112025-11-18
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
early anticoagulation, late anticoagulation - Mitral Regurgitation, Atrial Fibrillation
Phase 4Enrolling by invitationNational Institute of Cardiology, Warsaw, Poland4102022-03-132026-09-17
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation
unfractionated heparin, Sodium Citrate - Apheresis, Anticoagulation
Phase 4CompletedUniversity Medical Centre Ljubljana152022-01-212023-11-29
Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition
Apixaban single dose, Apixaban steady-state - Short Bowel Syndrome, Anticoagulation
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven702020-12-202026-10-15
Efficiency and Biocompatibility in Hemodiafiltration Procedure
Heparin anticoagulation, Citrate anticoagulation - End Stage Renal Disease on Dialysis, Biocompatibility
Phase 4CompletedUniversity Medical Centre Ljubljana202019-02-012025-02-04
Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)
four factor prothrombin complex concentrate - Anticoagulation, Anticoagulation Reversal
Phase 4UnknownBrigham and Women's Hospital502018-03-152021-05-05
Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
Apixaban - Anticoagulation
Phase 4CompletedBristol-Myers Squibb5572015-03-242019-11-29
Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass
Heparin fixed doses, PO continuous infusion of Protamine, Heparin and protamine titration - Cardiac Surgery, Cardiopulmonary Bypass
Phase 4CompletedSANE-Society of Anesthesiology2402009-07-012010-12-28

Narrower conditions

Atrial Fibrillation (1)  ·  Mitral Valve Insufficiency (1)  ·  Short Bowel Syndrome (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arrhythmias, Cardiac (1)  ·  Cardiovascular Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)  ·  Intestinal Diseases (1)  ·  Malabsorption Syndromes (1)  ·  Postoperative Complications (1)

Interventions

Heparin (2)  ·  apixaban (2)  ·  Rivaroxaban (1)  ·  Sodium Citrate (1)  ·  Warfarin (1)

Sponsors

RenJi Hospital (2)  ·  University Medical Centre Ljubljana (2)  ·  Brigham and Women's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  National Institute of Cardiology, Warsaw, Poland (1)  ·  SANE-Society of Anesthesiology (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

Slovenia (2)  ·  Belgium (1)  ·  Brazil (1)  ·  China (1)  ·  India (1)  ·  Poland (1)  ·  United States (1)

Top investigators

Jean M Connors, MD (1)  ·  Maria B Chuquer, M. D. (1)  ·  Milena Andonova, MD (1)

Results publications

PMID 38401649, PMID 38521486, PMID 39900192, PMID 41213699